Texarkana Division Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 1621 Arkansas Blvd, Texarkana, AR 71854 Phone: 870-774-7645 Fax: 870-773-7647 |
William Todd Hegmann Dds, Ms Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 1015 E 35th St, Texarkana, AR 71854 Phone: 870-773-3119 Fax: 870-772-7347 |
Randall A. Ellis, Dds, Pllc Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 312 Arkansas Blvd, Texarkana, AR 71854 Phone: 870-772-1374 Fax: 870-774-6814 |
Kevin B Seddens Ddspllc Clinic/Center - Dental Medicare: Not Enrolled in Medicare Practice Location: 1401 Dudley St, Texarkana, AR 71854 Phone: 870-330-7350 Fax: 870-330-7347 |
Arklatex Family Dental Center Dentist Medicare: Not Enrolled in Medicare Practice Location: 421 Pecan St, Texarkana, AR 71854 Phone: 870-779-0411 |
Michael Wharton-palmer Dentist - Pediatric Dentistry Medicare: Not Enrolled in Medicare Practice Location: 1702 Arkansas Blvd, Texarkana, AR 71854 Phone: 870-774-3278 Fax: 870-772-4593 |
News Archive
House Energy and Commerce Subcommittee on Health Chair Nathan Deal (R-Ga.) on Thursday said Congress has "plenty of time" prior to midterm elections to pass legislation that would promote the implementation of health care information technology, CQ HealthBeat reports (Reichard, CQ HealthBeat, 9/7).
If past hospitalizations for pneumonia and other respiratory illnesses are any guide, many Americans could face high out-of-pocket medical costs for COVID-19 hospitalizations despite the fact that many insurers have waived their cost-sharing requirements, a study from researchers at Johns Hopkins Bloomberg School of Public Health suggests.
A study by an international research group identified 15 novel biomarkers that are linked to late-onset dementias. These biomarkers are proteins, which predict cognitive decline and subsequent increased risk of dementia already 20 years before the disease onset.
The results of two new large scale trials show that the combination of dihydroartemisinin and piperaquine (DHA+PQP) not only is effective against uncomplicated malaria in a way which is comparable to other artemisinin-based combination therapies (ACTs), but it also protects patients against new infections for at least two months after treatment.
› Verified 5 days ago